Work

SPL84 and Trikafta® exhibit comparable and additive effects in patient-derived HBE cells carrying the 3849+10kb C→T/F508del CFTR variants

Year: 2026

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/j.jcf.2026.06.005

Authors: Yi Cheng, Yifat S. Oren, Jan Harrington, Aurélie Hatton, Efrat Ozeri-Galai, Chava D. Stampfer, Tamar Mordechai, Ofra Barchad-Avitzur, Gili Hart, Kevin Coote, Hermann Bihler, Isabelle Sermet-Gaudelus, Martin Mense, Batsheva Kerem

Institutions: Cystic Fibrosis Foundation, Hadassah Medical Center, Inserm, Institut Necker Enfants Malades, Hebrew University of Jerusalem

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7166191358

FWCI:

Cites: 28

Cited by:

Related to: